The cell cycle and transcription by RNA polymerase II (RNAP II) are closely
related. They utilize shared components. RNAP II transcriptional activity
is modulated during the cell cycle. Cell cycle dependent changes in the pho
sphorylation status of the carboxyl-terminal domain (CTD) of the largest su
bunit of RNAP II (RNAP II-LS) alter transcription. Several CTD kinases are
members of the cyclin-dependent kinase (cdk) superfamily, including p34(cdc
2) (cdk1), cdk7, cdk8, and cdk9. Each of these cdks, with their respective
cyclin partners, have been linked to cell cycle regulatory events. Other CT
D kinases such as casein kinase II (CKII) and c-abl have also been implicat
ed in cell cycle dependent modifications of the CTD. In addition, the stall
ing of RNAP II complexes at DNA lesions helps stimulate p53 accumulation wh
ich largely determines the cell's DNA damage response, including cell cycle
arrest. Alzheimer's disease pathology results partially from activation of
mitotic cdks in postmitotic neurons which can phosphorylate RNAP II-LS and
other targets.